Enovis Corp (ENOV) recent quarterly performance of -11.57% is not showing the real picture

Steve Mayer

Witnessing the stock’s movement on the chart, on Wednesday, Enovis Corp (NYSE: ENOV) set off with pace as it heaved 4.78% to $31.78, before settling in for the price of $30.33 at the close. Taking a more long-term approach, ENOV posted a 52-week range of $25.47-$49.83.

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -4.65%. Meanwhile, its Annual Earning per share during the time was -4.65%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.18%. This publicly-traded company’s shares outstanding now amounts to $57.16 million, simultaneously with a float of $55.91 million. The organization now has a market capitalization sitting at $1.82 billion. At the time of writing, stock’s 50-day Moving Average stood at $30.25, while the 200-day Moving Average is $35.36.

Enovis Corp (ENOV) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Enovis Corp’s current insider ownership accounts for 2.18%, in contrast to 118.81% institutional ownership. According to the most recent insider trade that took place on Sep 11 ’25, this organization’s Chief Executive Officer bought 6,457 shares at the rate of 30.97, making the entire transaction reach 199,973 in total value, affecting insider ownership by 102,753. Preceding that transaction, on Aug 22 ’25, Company’s SVP and Chief Legal Officer bought 3,200 for 31.41, making the whole transaction’s value amount to 100,512. This particular insider is now the holder of 43,515 in total.

Enovis Corp (ENOV) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.86 per share during the current fiscal year.

Enovis Corp’s EPS increase for this current 12-month fiscal period is 10.18% and is forecasted to reach 3.51 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 12.25% through the next 5 years, which can be compared against the -4.65% growth it accomplished over the previous five years trading on the market.

Enovis Corp (NYSE: ENOV) Trading Performance Indicators

Let’s observe the current performance indicators for Enovis Corp (ENOV). It’s Quick Ratio in the last reported quarter now stands at 1.15. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.83.

In the same vein, ENOV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -14.78, a figure that is expected to reach 0.65 in the next quarter, and analysts are predicting that it will be 3.51 at the market close of one year from today.

Technical Analysis of Enovis Corp (ENOV)

Going through the that latest performance of [Enovis Corp, ENOV]. Its last 5-days volume of 0.59 million was inferior to the volume of 1.14 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 54.63% While, its Average True Range was 56.03.

Raw Stochastic average of Enovis Corp (ENOV) in the period of the previous 100 days is set at 55.61%, which indicates a major fall in contrast to 61.43% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.10 that was lower than 1.18 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.